Joseph M. Woodland - Concepedia

Author

Joseph M. Woodland

Eli Lilly (United States)

Also Known As

J M Woodland, J. Woodland Hastings, Joseph M. Woodland, Joseph Woodland

Publications

200

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Joseph M. Woodland is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	184
2	Biochemistry	6	6	170
3	Natural Sciences	3	3	90
4	Biomolecular Engineering	1	1	35
5	Chemical Biology	1	1	35

Joseph M. Woodland

Publications

184

Citations

H-Index

Page 1

	Year	Citations
The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products Haydee E. P. Bazán, S. Reddy, Joseph M. Woodland, Biochemical and Biophysical Research Communications InflammationThrombopoiesisLipoxygenase ProductsBiochemistryBlood Platelet	1987	44
Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations. William J. Ehlhardt, Joseph M. Woodland, Todd M. Baughman, PubMed Metabolomic ProfilingMedicinal ChemistryNovel MetabolitesBioanalysisCompound Ly335979	1998	40
Novel Acid Labile COL1 Trityl-Linked Difluoronucleoside Immunoconjugates: Synthesis, Characterization, and Biological Activity<sup>1</sup> Vinod F. Patel, Julie N. Hardin, John M. Mastro, Bioconjugate Chemistry Medicinal ChemistryBiochemistryMedicineDrug DiscoveryNatural Sciences	1996	35
Metabolism and disposition of the antifolate LY231514 in mice and dogs. Joseph M. Woodland, Chris J. Barnett, Douglas E. Dorman, PubMed Antifolate Ly231514Experimental PharmacologyParent Ly231514Laboratory Animal StudyMolecular Pharmacology	1997	24
Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas William J. Ehlhardt, Joseph M. Woodland, John F. Worzalla, Chemical Research in Toxicology Pharmaceutical ScienceMetabolic FormationAnticancer Agent SulofenurSecondary MetaboliteRelated Sulfonylureas	1992	15
SAR and biological evaluation of novel trans-3,4-dimethyl-4-arylpiperidine derivatives as opioid antagonists Mark J. Benvenga, Paul J. Emmerson, Ryan Favors, Bioorganic & Medicinal Chemistry Letters Opioid AntagonistsPharmacologyPharmacological AgentPharmacotherapyBiological Evaluation	2005	14
Disposition and metabolism of the sulfonylurea oncolytic agent LY295501 in mouse, rat, and monkey. William J. Ehlhardt, Joseph M. Woodland, John E. Toth, PubMed BiochemistryMedicinePhysiologyMetabolomic ProfilingSaturated Ring	1997	12

Page 1